Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 287 $ (1,680) $ 175,820 $ (141,489) $ 32,938
Balance, shares at Dec. 31, 2018 2,877,000 7,000      
Common stock issued $ 1 1
Common stock issued, shares 9,000      
Restricted stock issued
Restricted stock issued, shares      
Common stock issued through market sales
Common stock issued through market sales, shares      
Common stock issued through offerings, net of expenses $ 94 5,868 5,962
Common stock issued through offerings, net of expenses, shares 933      
Extinguishment of Series A Shares
Beneficial Conversion Feature in connection with Series B Issuance
Amortization of Beneficial Conversion Feature
Treasury stock purchased $ (32) (32)
Treasury stock purchased, shares 3,000      
Stock-based compensation expense 266 266
Adoption of ASC 842 55 55
Net loss (3,419) (3,419)
Balance at Mar. 31, 2019 $ 382 $ (1,712) 181,954 (144,853) 35,771
Balance, shares at Mar. 31, 2019 3,819,000 10,000      
Balance at Dec. 31, 2018 $ 287 $ (1,680) 175,820 (141,489) 32,938
Balance, shares at Dec. 31, 2018 2,877,000 7,000      
Net loss         (8,639)
Balance at Jun. 30, 2019 $ 383 $ (1,712) 182,231 (150,073) 30,829
Balance, shares at Jun. 30, 2019 3,829,000 10      
Balance at Mar. 31, 2019 $ 382 $ (1,712) 181,954 (144,853) 35,771
Balance, shares at Mar. 31, 2019 3,819,000 10,000      
Common stock issued $ 1 72 73
Common stock issued, shares 10,000      
Treasury stock purchased
Treasury stock purchased, shares      
Stock-based compensation expense 205 205
Net loss (5,220) (5,220)
Balance at Jun. 30, 2019 $ 383 $ (1,712) 182,231 (150,073) 30,829
Balance, shares at Jun. 30, 2019 3,829,000 10      
Balance at Dec. 31, 2019 $ 393 $ (1,721) 182,514 (168,160) 13,026
Balance, shares at Dec. 31, 2019 3,932,000 12,000      
Common stock issued $ 1 1
Common stock issued, shares 37,000      
Restricted stock issued
Restricted stock issued, shares 6,000      
Common stock issued through market sales $ 8 476 484
Common stock issued through market sales, shares 80,000      
Common stock issued through offerings, net of expenses
Common stock issued through offerings, net of expenses, shares      
Extinguishment of Series A Shares (828) (828)
Beneficial Conversion Feature in connection with Series B Issuance 2,205 2,205
Amortization of Beneficial Conversion Feature (2,205) (2,205)
Treasury stock purchased
Treasury stock purchased, shares      
Stock-based compensation expense 418 418
Adoption of ASC 842
Net loss (6,263) (6,263)
Balance at Mar. 31, 2020 $ 402 $ (1,721) 182,580 (174,423) 6,838
Balance, shares at Mar. 31, 2020 4,055,000 12,000      
Balance at Dec. 31, 2019 $ 393 $ (1,721) 182,514 (168,160) 13,026
Balance, shares at Dec. 31, 2019 3,932,000 12,000      
Net loss         (14,792)
Balance at Jun. 30, 2020 $ 402 $ (1,770) 182,980 (179,919) 1,693
Balance, shares at Jun. 30, 2020 4,055,000 19,000      
Balance at Mar. 31, 2020 $ 402 $ (1,721) 182,580 (174,423) 6,838
Balance, shares at Mar. 31, 2020 4,055,000 12,000      
Common stock issued
Common stock issued, shares      
Treasury stock purchased $ (49) (49)
Treasury stock purchased, shares 7,000      
Stock-based compensation expense 400 400
Adoption of ASC 842      
Net loss (5,469) (5,496)
Balance at Jun. 30, 2020 $ 402 $ (1,770) $ 182,980 $ (179,919) $ 1,693
Balance, shares at Jun. 30, 2020 4,055,000 19,000